Inhibiting CD39 or CD73 by small-molecule inhibitors or blocking antibody markedly reduced the inhibition of CD4+ and CD8+ T cell responses and meanwhile elevated the cytotoxic activity of CTL and NK cells, resulting in tumor cells being killed [203]. Here, CD8A is linked to neoplasm.